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Infection is a common and severe complication of burn injury: Sepsis accounts for 47%
of postburn mortality. Burn-induced T cell suppression likely contributes to the increased
infection susceptibility in burn patients. However, little is known about the kinetics of
T cell dysfunction after burn and its underlying mechanisms. In this study, we show in a
murine scald injury model that T cell activation of both CD4+ and CD8+ T cells as well
as T cell cytokine production is suppressed acutely and persistently for at least 11 days
after burn injury. Purified T cells from scald-injured mice exhibit normal T cell functions,
indicating an extrinsically mediated defect. We further show that T cell dysfunction after
burn appears to be cell-to-cell contact dependent and can be ameliorated by depletion
of myeloid-derived suppressor cells. These cells expand after burn injury, particularly
a subset expressing the checkpoint inhibitor CD172a, and infiltrate germinal centers.
Expression of CD172a appears to be driven by ingestion of immature reticulocytes.
Immature reticulocytes are drastically increased in the spleen of scald mice and may
contribute to immunosuppression through more direct mechanisms as well. Overall,
our study newly identifies two cell populations, myeloid-derived suppressor cells and
immature reticulocytes, as well as the CD47/CD172a-signaling pathways as mediators
of T cell suppressors after burn and thus opens up new research opportunities in the
search for new therapies to combat increased infection susceptibility and the associated
morbidity and mortality in burn victims.
Keywords: adaptive immunity, immunosuppression, myeloid-derived suppressor cells, immature reticulocytes,
immune-checkpoint inhibitors
INTRODUCTION
Infection is a common complication of burn injury, caused by skin barrier-loss and burn-induced
immunosuppression. Despite the best prevention efforts, patients that do acquire an infection
after burn injury suffer from increased morbidity and have a higher mortality risk. Investigators
have previously determined that 47% of postburn mortality was the result of sepsis (1). To give
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burn victims their best chance of survival and provide them with
the best possible care, a better understanding of burn-related
immune dysfunction is urgently needed.
It is well-established that the early response to an infection is
driven by innate immunity. Classically, the onset of the adaptive
response was thought to occur after the innate response had
subsided. However, research in the past decade has established
a role of adaptive immunity in the acute response to an infection
as well. In particular, T cells play a key role. T cell can enhance
early innate function through production of IFN-γ and IL-17
(2). Additionally, regulatory and Th2 CD4+ T cells are known
to mediate inflammation resolution (3).
T cells function and numbers are commonly decreased in
critically ill burn patients (4–6). Indeed, decreases in IFN-
γ, IL-2, and IL-12, and an increase in IL-4, IL-10, and IL-
13 have been reported in both thermally injured patients and
animal models (7–19). Further, it has been widely observed
that following trauma, T cells undergo apoptosis (20–23).
This could diminish TCR diversity through depletion of T
cell clones and thus impair T cell effector functions against
invading pathogens, which require a large repertoire of unique
T cell receptors (TCRs). Additionally, apoptotic cells are capable
of inhibiting the inflammatory program by releasing anti-
inflammatory cytokines such as TGFβ and IL-10 (24, 25). They
also release Annexin I, which attenuates IL-6 signaling and
TNFα release from monocytes (26) and Lactoferrin, which
inhibits neutrophil chemotaxis (27). In contrast to suppressing
neutrophil recruitment, apoptotic cells induce the recruitment of
macrophages, which clear apoptotic cells through phagocytosis
(28). This triggers even more anti-inflammatory mechanisms,
as it decreases macrophage production of GM-CSF, IL-1, IL-
8, and TNFα, increases the production of TGFβ, PGE2, and
PAF (29) and the release of pro-resolving lipid mediators,
such as resolvins, protectins and maresin (30–32). Additionally,
efferocytosis results in immune checkpoint expression: In sepsis
studies, apoptosis of T cells has been linked to both increased
expression of immune checkpoint inhibitor ligands (i.e., PD-
L1) on myeloid cells, as well as their corresponding receptors
on T cells (33–36). In addition to inducing T cell apoptosis,
checkpoint inhibitor receptor/ligand interactions contribute to
immunosuppression by inducing T cell exhaustion, which is
characterized by a loss of T cell effector functions and decreased
proliferation (37).
Targeting these changes could be a promising therapeutic
approach to fight susceptibility to infections in burn patients.
Data from septic patients show that patients whose TCR diversity
remains low are at an increased risk for nosocomial infections
and death (38) and in experimental sepsis models, the use of
anti-apoptotic cytokine IL-7 improved survival, restored IFN-γ
production and improved immune effector cell recruitment to
the site of infection (39). In sepsis trials, the blockage of inhibitory
immune checkpoints showed therapeutic efficacy (40, 41). More
recently, anti-PD-L1 therapy was also shown to be effective in a
murine model of scald injury and bacterial infection (42).
A novel concept of T cell suppression is immune-modulation
by immature reticulocytes. Immature reticulocytes are precursors
of red blood cells (RBCs). While they are normally generated in
the bone marrow, stress conditions can induce extramedullary
hematopoiesis, resulting in the presence of immature
reticulocytes in the periphery (43). Immature reticulocytes
express the erythroid lineage marker CD235 (human)/Ter119
(murine), transferrin receptor (CD71), VLA-4 (CD49d) and have
residual RNA. The expression/presence of the last three decreases
with increasingmaturation (44–46). Immature reticulocytes were
first attributed immunosuppressive properties by hampering
immune cell activation and cytokine production through
arginase 2 in a study using newborn mice, expanding the old
concept that neonatal infection susceptibility is solely based on
an underdeveloped immune system (44). In a newborn bacterial
infection model, immature reticulocytes inhibited phagocytosis
of Bordetella pertussis and their depletion with an anti-CD71
antibody significantly increased IFN-γ, IL-17 and anti-B.
pertussis-antibody production (47). Immature reticulocytes
have also been reported to express various immune checkpoint
inhibitors (48–50). In co-incubation experiments, purified
immature reticulocytes altered CD8+ T cell activation, inhibited
conventional CD4+ and CD8+ T cell expansion, suppressed
expansion of CD8+ regulatory cells, regulated cytokine responses
to microbial products by myeloid cells and indirectly modulated
T cell cytokine responses (49). Immature reticulocytes have
also been observed in adults with hepatocellular carcinoma,
which was associated with splenomegaly and promoted tumor
progression through artemin production (51). In another tumor
model, CD45+ Ter119+ CD71+ cells were identified as robust
immunosuppressors (52). The study did not address why these
cells express both the myeloid marker CD45 and the erythroid
marker Ter119, but does show that the transcriptome of these
cells closely resembles that of myeloid-derived suppressor cells
(52). A possible explanation is that this population represents
myeloid cells that ingested immature reticulocytes. Another
interesting observation of the study is that these tumor-bearing
mice were anemic, despite the increase in immature reticulocytes,
indicating a blockage of erythrocyte maturation. Burn injury is
known to cause anemia as well (53), however, the occurrence
of immature reticulocytes after burn injury has not been
investigated in detail yet.
The aim of this study was to determine the functionality of
T cells in a time course after scald injury, since little is known
so far about the duration of burn-induced T cell dysfunction.
We also aimed to gain further mechanistic insights into burn-
induced T cell dysfunction with regard to the mediating cell
types and pathways involved, in the hope of identifying novel




Male CD1 IGS mice were obtained from Charles River
laboratories (Wilmington, MA) at 5 weeks of age and allowed
to acclimate for 1 week prior to conducting experiments. All
mice were housed in standard environmental conditions with
ad-libitum access to pellet diet and water. All experiments were
conducted between 8 and 11 a.m. using protocols approved by the
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FIGURE 1 | Scald injury persistently impairs T cell activation. CD1 outbred mice were subjected to scald injury (28% total body surface area (TBSA), full thickness).
Controls did not undergo the procedure. Spleens were harvested on the indicated days after injury and splenocytes cultured for 24 h (A,B) or 48 h (C,D) in the
presence of anti-CD3/CD28 coated beads. CD4+ (A,C) and CD8+ (B,D) T cell activation was determined by CD69 (A,B) and CD25 (C,D) positivity by flow cytometry.
Graphs depict means ± SEM from two independent experiments in addition to each replicate. n = 8 (d1–d9), n = 12 (d11). Outliers were removed when permissible
by ROUT method. *p < 0.05 compared to respective control (one-way ANOVA with Sidak posttest).
Institution of Animal Care and Use Committee of the University
of Cincinnati (IACUC number 08-09-19-01).
Scald Burn Injury
We used a scald burn model as previously described (54). Briefly,
6-week old mice were randomized into two groups: scald and
control. All mice were anesthetized with 4.5% isofluorane in
oxygen. The back of the mice was shaven prior to placing
them in a template exposing their dorsal surface, corresponding
to 28% of their total body surface area (calculation based on
the Meeh formula (55)). Scald mice were immersed in 90◦C
water for 9 s, yielding a full thickness, third degree, insensate
legion. Control mice were immersed in room-temperature water
instead. All mice were subsequently resuscitated intraperitoneally
with 1.5mL sterile normal saline. After the procedure, mice
were allowed to recover on a 42◦C heating pad for 3 h and
subsequently returned to their home cage. Mice were monitored
for any complications twice daily for the duration of the
entire experiment.
T Cell Re-stimulation
Mice were sacrificed by CO2 exposure and subsequent cervical
dislocation on the indicated days after scald injury. Spleens were
removed and splenocytes were isolated in RPMImedium (Lonza,
Basel Switzerland) by gently mashing them through 70µm filters
(Corning, Corning, NY). Cell numbers were determined on a
hemocytometer (Beckman Coulter, Brea, CA) and cells seeded
at a density of 2 Mio cells/mL in 48-well tissue culture plates.
Samples were stimulated with anti-CD3/CD28 coated Dynabeads
(ThermoFisher, Waltham, MS) at a 1:1 ratio of beads to cells.
Samples were incubated for 24 h or 48 h prior to assessment of
T cell activation by flow cytometry. When indicated, 2µg/mL
anti-CD172a (clone P84, BioLegend, San Diego, CA) or 2µg/mL
anti-CD47 (clone miap301, BioLegend) were added for the
duration of the stimulation.
Flow Cytometry Analysis
Cells were isolated and treated as described for the respective
experiment and analysis of cell surface antigen expression was
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FIGURE 2 | Scald injury persistently impairs cytokine production. CD1 outbred mice were subjected to scald injury (28% TBSA, full thickness). Controls did not
undergo the procedure (ctrl). Spleens were harvested on the indicated days after injury and splenocytes cultured for 24 h (A–C) or 48 h (D) in the presence of
anti-CD3/CD28 coated beads. IL-2 production was assessed by ELISPOT (A) The percentages of total and naïve T cells producing IFN-γ were determined by
intracellular staining and flow cytometry (B,C). IFN-γ production was quantified by cytometric bead assay (D). Graphs depict means ± SEM from two independent
experiments in addition to each replicate. n = 8 (controls), n = 12 (scald). For Figure 2D, the controls from each time-point were not significantly different from one
another and were pooled for better legibility. Outliers were removed when permissible by ROUT method. *p < 0.05 compared to control (one-way ANOVA with Sidak
(B,C) or Dunnett (A,D) posttest).
performed. For intracellular staining, cells were fixed with 1%
paraformaldehyde and permeabilized with 0.1% saponin. The
following fluorescent-labeled antibodies were used: CD4 (clone
RM4-5), CD8 (53-6.7), CD11b (clone M1/70), CD25 (clone PC-
61), CD44 (IM7), CD45 (clone 30-F11), CD62L (clone MEL-
14), CD69 (clone H1.2F3), CD155 (clone 3F1), CD172a (clone
P84), CD200 (clone OX-90), CD273 (clone TY25), CD274 (clone
MIH5), CD71 (clone RI7217), Gr1 (clone RB6-8C5), Ly6G
(clone 1A8), Ter119 (clone TER-119) (all BioLegend or BD
Bioscience, Franklin Lakes, NJ). Flow cytometry acquisition and
analysis were performed on an Attune Flow Cytometer (Life
Technologies, Foster City, CA).
Cytokine Analysis
The IL-2 ELISPOT (CTL, Cleveland, OH) was conducted
according to manufacturer’s instructions. 30,000 cells/well were
seeded and stimulated with anti-CD3/CD28 Dynabeads at a
1:1 ratio of beads to cells. IL-2 and IFN-γ concentrations
in supernatants of the splenocyte cultures were quantified
by cytometric bead assay (BD Bioscience) according to the
manufacturer’s instructions as previously described (56).
Cell Purification
T cells were purified from spleens by magnetic bead separation
using anti-CD90.2 microbeads (Miltenyi Biotec, Bergisch
Gladbach, Germany) on an autoMACS separator (Miltenyi
Biotec) according to the manufacturer’s instructions. Similarly,
Ter119+ cells were purified using the same system and anti-
Ter119 microbeads (Miltenyi Biotec). CD71+ cells were isolated
by jet-in-air cell sorting using an iSort Automated Cell Sorter
(ThermoFischer) after staining with AF488-labeled anti-CD71
(clone RI7217, BioLegend).
In vivo Gr1+ Cell Depletion
Mice were injected with 100 µg anti-Gr1 (clone RB6-8C5,
BioXCell, West Lebanon, NH) in 100 µL sterile PBS i.p. on
day 6 after scald injury. Spleens were harvested and neutrophil
depletion confirmed by flow cytometry.
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FIGURE 3 | T cell purification mitigates scald-induced T cell dysfunction. CD1 outbred mice were subjected to scald injury (28% TBSA, full thickness). Controls did
not undergo the procedure (ctrl). Spleens were harvested on day 7 after injury (d7), splenocytes isolated and CD90.2 positive cells purified by magnetic bead isolation.
These purified cells (mostly T cells, “pure”) were cultured in the presence of anti-CD3/CD28 coated beads. As a control, splenocytes from the same mice were
cultured without any purification (mixed leukocyte cultures as in Figure 1, “MLC”). Graphs depict means ± SEM of two independent experiments in addition to each
replicate. Outliers were removed when permissible by ROUT method. (A,B) CD4+ and CD8+ T cell activation at 24 h was determined as CD69 positivity by flow
cytometry. n = 8–10. *p < 0.05 compared to MLC control, #p < 0.05 compared to MLC d7 (one-way ANOVA with Sidak posttest. (C,D) IL-2 production was
quantified at 24 h by cytometric bead assay. n = 8–10. *p < 0.05 compared to control (Student t-test). (E,F) CD4+ and CD8+ T cell activation at 48 h was determined
as CD25 positivity by flow cytometry. n = 8–10. *p < 0.05 compared to MLC control, #p < 0.05 compared to MLC d7 (one-way ANOVA with Sidak posttest. (G,H)
IFN-γ production was quantified at 48h by cytometric bead assay. n = 4–6. * p< 0.05 compared to control (Student t-test).
Histology
Mice were sacrificed at the indicated times. Spleens were
harvested, fixed in 10% formalin for 48 h, dehydrated in 70%
ethanol for 72 h and embedded in paraffin. 5–10µm thick
sections were prepared and stained with hematoxylin and
eosin. For detection of Gr1+ cells, sections were incubated
with a primary antibody against anti-Gr1 (clone RB6-8C5, Bio-
Rad, Hercules, CA), followed by horseradish-labeled secondary
antibody and DAB. An isotype control was used to ensure
specificity of the Gr1 staining. Samples were imaged on a Zeiss
microscope. Invasion of Gr1+ cells into germinal centers was
quantified by a blinded, experienced investigator.
Statistics
Graphs depict each replicate in addition to the mean ± SEM.
ROUTmethod was used to test for statistically significant outliers
and data points were removed when the criteria were met (false
discovery rate Q = 1%). Two groups were compared by Student
t-test for unpaired samples or Wilcoxon signed-rank test for
paired observations. Selective comparisons of three or more
groups were calculated by ANOVA with the indicated posttest.
A p ≤ 0.05 was considered significant.
RESULTS
Scald Injury Persistently Impairs T Cell
Activation
It is established that burn injury causes T cell dysfunction,
but it is currently unclear how long the defect persists. To
address this question, we conducted a temporal study. Mice
were subjected to sham- or scald-injury, splenocytes were
harvested every other day until Post Burn Day 11 (PBD11)
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FIGURE 4 | in vivo depletion of Gr1+ cells mitigates scald-induced T cell dysfunction. CD1 outbred mice were subjected to scald injury (28% TBSA, full thickness).
Controls did not undergo the procedure (ctrl). When indicated, mice received an i.p. injection of 100 µg anti-Gr1 antibody (clone RB6-8C5) on day 6 after injury.
Spleens were harvested the next day (d7). Neutrophil numbers were determined by flow cytometry (A) and splenocytes were cultured for 24 h (B,C) or 48 h (D,E) in
the presence of anti-CD3/CD28 coated beads. T cell activation was determined by CD69 (B,C) and CD25 (D,E) positivity by flow cytometry. Graphs depict means ±
SEM of two independent experiments in addition to each replicate. n = 8–9. Outliers were removed when permissible by ROUT method. *p < 0.05 compared to ctrl -,
#p < 0.05 compared to d7 - (one-way ANOVA with Sidak posttest).
and stimulated with anti-CD3/CD28 coated beads ex vivo.
Early T cell activation, as indicated by CD69 positivity at 24 h,
was persistently impaired on both CD4+ and CD8+ T cells
with the exception of PBD3 (Figures 1A,B). Similarly, late T
cell activation, as indicated by CD25 positivity at 48 h, was
persistently decreased as well, starting on PBD3 in CD4+ T cells
and on PBD1 in CD8+ cells. Neither parameter showed a
clear indication of a beginning recovery on PBD11. We also
analyzed T cell apoptosis upon ex vivo stimulation, but did not
detect significant differences between controls and scalds at any
timepoint (data not shown).
Scald Injury Persistently Impairs Cytokine
Production
To determine whether impaired T cell activation is also
accompanied by reduced functionality, we assessed cytokine
production in a similar temporal manner. Fewer splenocytes
from scald injured mice were able to produce IL-2 upon
ex vivo stimulation. The defect became significant by PBD5
and persisted until PBD11 (Figure 2A). Production of IFN-γ
by T cells was elucidated on PBD7 and scald mice showed
a reduced percentage of total CD8+ cells and particularly
naïve CD8+ cells producing IFN-γ upon ex vivo stimulation
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FIGURE 5 | Immune-checkpoint inhibitor expressing Gr1+ cells increase and infiltrate germinal centers after burn injury. CD1 outbred mice were subjected to scald
injury (28% TBSA, full thickness). Controls did not undergo the procedure (ctrl). Spleens were harvested on day 7 after injury (d7). Formalin-fixed, paraffin-embedded
tissue sections were stained with an anti-Gr1 antibody and counterstained with hematoxylin. Scale bar indicates 1,000µm. (A) Based on these sections, the
percentage of germinal centers that show invasion of Gr1+ cells was determined by a blinded, experienced investigator. Four spleens per group and five entire
sections per spleen were counted. Data points show the average percentage per individual spleen (B). Numbers of total Gr1+ cells (C), as well as the numbers of
Gr1+ cells expressing various checkpoint inhibitors (D) were quantified in freshly isolated, unfixed spleens by flow cytometry. Graphs depict means ± SEM in addition
to each replicate. n = 4 (A,B,D), n = 12–15 (C). Outliers were removed when permissible by ROUT method. *p < 0.05 compared to respective control [Student t-test
(B,C) or one-way ANOVA with Sidak posttest (D)].
(Figures 2B,C). Quantification of IFN-γ production by the ex
vivo splenocyte cultures showed a significant reduction starting
on PBD1 and persisting until PBD11 with no indication of a
beginning recovery.
T Cell Purification Mitigates Scald-Induced
T Cell Dysfunction
Given that the previous results were obtained from whole
splenocyte cultures, it is unclear whether the observed defects
constitute and intrinsic defect of the T cells, or if they are
mediated by cell-to-cell contact with inhibitory cells and/or
the release of soluble inhibitory factors by non-T cells.
Initially, we examined spleen histology after scald injury
and noted indications of extramedullary hematopoiesis in
the red pulp, while the lymphocyte zones seemed intact
(Figure S1A). This potentially indicated an extrinsic, cell-
mediated mechanism. In line with this, we noted a negative
correlation between T cell activation and spleen/body mass
ratio in PBD7 samples (Figure S1B). To support this
further, we purified T cells using anti-CD90.2 magnetic
bead separation and compared T cell activation in these
purified samples to the mixed lymphocyte cultures (MLC).
Purification of T cells from PBD7 samples significantly
improved CD4+ and CD8+ T cell activation at both 24 h
and 48 h (Figure 3). To address the question of whether the
extrinsic suppression of T cells after burn injury is contact
dependent, or whether a soluble mediator is responsible,
we incubated control splenocytes with PBD7 splenocytes,
but separated the two by a cell-impermeable mesh. Control
splenocytes maintained normal T cell activation in this
setting (Figure S1C), arguing against an impairment due to
soluble mediators.
In vivo Depletion of Gr1+ Cells Mitigates
Scald-Induced T Cell Dysfunction
To determine which cell type mediates the observed T cell
dysfunction, we depleted Gr1+ cells in vivo by injection of
an anti-Gr1 antibody on PBD6 and assessed T cell activation
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FIGURE 6 | Ex vivo blockage of the CD172a ligand CD47 mitigates
scald-induced T cell dysfunction. CD1 outbred mice were subjected to scald
injury (28% TBSA, full thickness). Spleens were harvested on day 7 after injury
and cultured for 24 h in the presence of anti-CD3/CD28 coated beads and
with or without 2µg/mL anti-CD47. CD4+ (A) and CD8+ (B) T cell activation
was determined by CD69 positivity by flow cytometry. Graphs depict paired
data from individual scald mice of two independent experiments. n = 12. *p <
0.05 compared to control (Wilcoxon signed-rank test).
the next day. Scald injured mice showed a significant increase
in splenic neutrophils on PBD7, which was successfully
depleted by anti-Gr1 antibody injection (Figure 4A). Gr1+
cell depletion significantly improved CD4+ and CD8+ T
cell activation and both 24 h and 48 h (Figures 4B–E). A
similar ameliorative effect on T cell activation was not
observed upon neutrophil depletion using an anti-Ly6G specific
antibody, despite successful reduction of splenic neutrophil
numbers (Figure S2).
Immune-Checkpoint Inhibitor Expressing
Gr1+ Cells Increase and Infiltrate Germinal
Centers After Burn Injury
Given the amelioration of burn-induced T cell dysfunction
upon Gr1+ cell depletion, we next investigated these cells in
more detail. Histologically, PBD7 spleens showed an increase in
Gr1+ cells (Figure 5A), which was confirmed by flow cytometry
(Figure 5C). Importantly, histology showed an increase of Gr1+
cells into germinal centers in PBD7 samples, while they are
normally confined to the red pulp (Figures 5A,B). This is of
note because the germinal centers constitute the lymphocyte
zones in the spleen, so the invading Gr1+ cells could be in
direct contact with the splenic T cells. To assess how the Gr1+
cells induce T cell suppression, we quantified the numbers of
checkpoint-inhibitor expressing Gr1+ cells by flow cytometry.
The populations of CD172a, CD200 and CD273-expressing
Gr1+ cells were significantly increased upon scald injury, with
the CD172a+ subset showing the most pronounced increase
(Figure 5D).
Ex vivo Blockage of CD47, but Not CD172a
Mitigates Scald-Induced T Cell Dysfunction
Given the pronounced expansion of CD172a+ Gr1+ cells after
burn injury and the successful restoration of T cell activation
upon Gr1+ cell depletion, we wanted to assess if we could
specifically block interactions of CD172a with its receptor,
CD47, to ameliorate T cell dysfunction after burn. For this, we
re-stimulated splenocytes ex vivo with anti-CD3/CD28 coated
beads in the presence of anti-CD47. Blockage of CD172a
did not improve CD4+ or CD8+ T cell activation (data not
shown), but blockage of CD47 did significantly improve CD4+
T cell activation (Figure 6A), albeit not CD8+ T cell activation
(Figure 6B).
Scald Injury Leads To an Expansion of
Immature Reticulocytes, Driving
Checkpoint-Inhibitor Expression on Gr1+
Cells
Previous studies have established a role of immature reticulocytes
in T cell suppression (44, 47, 49). In one tumor model,
CD45+ Ter119+ CD71+ cells were identified as robust
immunosuppressors, whose transcriptome strongly resembled
that of myeloid-derived suppressor cells (52). The study did not
investigate why these cells express both CD45 and Ter119, but
one conceivable explanation is that myeloid-derived suppressor
cells ingested the immature reticulocytes. Another interesting
finding of the study is that the tumor-bearing mice were anemic
despite the increase in immature reticulocytes, indicating a
blockage of erythrocyte maturation. This would be in line with
a clearance of the precursor cells by myeloid-derived suppressor
cell ingestion as well. Given the observed T cell dysfunction after
burn injury on top of signs of extramedullary hematopoiesis in
our model (Figure S1A) and the knowledge that burn injury
also frequently causes anemia (53), we hypothesized that there
may be an expansion of immature reticulocytes in the spleens
after burn injury. Ingestion of these cells by the expanding Gr1+
cell population could drive their immune checkpoint inhibitor
expression similar to what is known after efferocytosis (33–36).
To test this, we first determined numbers of immature
reticulocytes in spleens in a time course after burn injury.
Immature reticulocytes were considered CD45−, Ter119+, and
CD71+. We further confirmed the separation into mature
and immature cells by determining CD49d expression and the
presence of residual RNA and DNA by thiazole orange staining
(Figure S3). We found an increase in immature reticulocytes,
which became significant on PBD7 and continued until PBD11
(Figure 7A). To determine whether other splenocytes could
ingest these cells, we incubated control splenocytes with CFSE-
labeled CD71+ purified cells isolated from scald injured mice.
Upon co-incubation, a CFSE-positive population of splenocytes
was observed. Trypan blue addition did not quench the CFSE
signal in these cells, indicating that the splenocytes ingested the
CFSE-labeled CD71+ cells (Figure 7B).
To test our hypothesis that ingestion drives CD172a
expression, we conducted a similar co-incubation with CFSE-
labeled Ter119+ cells obtained from scald-injured mice. Gr1+
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cells that ingested Ter11+ cells (positive for CFSE) showed
higher expression of CD172a compared to those Gr1+ cells that
did not (Figure 7C). To test whether similar ingestion occurs
in vivo, we elucidated the numbers of Gr1+ cells with ingested
immature reticulocytes based on intracellular CD71 and Ter119
staining after burn on those days that showed a significant
increase in immature reticulocytes in the previous time course.
For all three tested days (PBD7, PBD9, and PBD11), we noted a
significant increase in Gr1+ cells which had ingested immature
reticulocytes (Figure 7D). Compared to Gr1+ cells that did not
ingest immature reticulocytes, those Gr1+ cells that did ingest
them showed higher CD172a expression in both control and
PBD7 cells (Figure 7E).
DISCUSSION
It’s been previously established that burn injury causes T cell
dysfunction. However, the duration of this dysfunction is unclear.
In order to determine if T cell function is only impaired in the
acute phase after burn or whether the changes persist long-term,
we conducted a temporal study. We observed suppressed CD4+
and CD8+ T cell activation, as well as reduced IL-2 and IFN-
γ production in the acute phase after burn, as well as up to 11
days after the injury. Neither activation nor cytokine production
showed a clear indication of a beginning of recovery on PBD11.
While there is no straight-forward algorithm to relate mouse days
to human years, a general rule of thumb is that 9 days for a
mouse constitute one human year (57). Thus, our data indicates
that burn victims could demonstrate reduced T cell functionality
for well over 1 year following the injury. This is in line with
population studies, which found that burn patients exhibited a
heightened risk for respiratory infections in the first five years
following burn injury (58). Given that the leading cause of burn-
related mortality are infections, this highlights the urgent need
for clinical interventions (1).
The key to targeting burn-induced T cell dysfunction
therapeutically is to understand the underlying mechanisms
and identify potential interventions for mitigation. We first
tested the hypothesis on whether the dysfunction is intrinsic
to the T cells, or if it is instead mediated by an inhibitory
cell. We noted enlarged spleens with evidence of extramedullary
hematopoiesis in the red pulp after burn injury in our model,
while the white pulp seemed inconspicuous. Additionally,
higher spleen to body mass ratios in scald mice negatively
correlated with T cell activation. Both indicated a potential
cell-mediated defect. To test this, we assessed T cell activation
in purified T cells and noted a significant improvement of
functionality compared to mixed lymphocyte cultures. Further,
control T cells maintained proper activation in the presence
of mixed splenocytes obtained from scald mice, when the two
populations were separated by a cell-impermeable mesh. This
indicates that burn-induced T cell dysfunction is not mediated
by a soluble mediator, but rather by a cell-to-cell contact
dependent defect.
In order to identify the responsible inhibitory cell type, we
depleted Gr1+ cells in vivo using an anti-Gr1 specific antibody.
Gr1, a shared epitope of Ly6G and Ly6C surface antigens, is the
murine marker for myeloid-derived suppressor cells (MDSCs).
This cell type has known immunosuppressive functions and
has been associated with disease severity, nosocomial infections
and mortality in sepsis studies (59). Depletion of Gr1+
cells in vivo significantly ameliorated burn-induced T cell
dysfunction in our model. This was specific to the depletion
of Gr1+ cells, since neutrophil depletion with a Ly6G-specific
antibody had no such effect. While the role of MDSCs in
sepsis has been studied, little is known about this cell type
with regard to burn injury, other than that these cells have
been found to infiltrate the burn wound (60). Our study
shows an expansion of splenic Gr1+ cells in response to
burn injury, as well as an infiltration of Gr1+ cells into the
germinal centers. In healthy controls, Gr1+ cells are confined
to the red pulp. The infiltration into the germinal centers
is noteworthy, since germinal centers are lymphocyte zones.
Thus, the infiltrating Gr1+ cells could be in direct contact with
splenic T cells in vivo, which, based on our previous data, is a
prerequisite for burn-induced T cell suppression. Common cell-
contact-dependent immunosuppressive mediators of MDSCs are
checkpoint inhibitory receptors. We noted significant increases
in Gr1+ cells expressing the checkpoint inhibitors CD200 (OX-
2) and CD273 (PD-L2), but the expansion of CD172a expressing
Gr1+ cells after burn injury was the most pronounced, with an
approx. 6-fold increase.
In light of the increase of CD172a-expressing Gr1+ cells
after burn, we wanted to assess if we could specifically block
interactions of CD172a with its receptor, CD47, to ameliorate
T cell dysfunction. In vitro use of an anti-CD172a antibody did
not improve T cell activation, but anti-CD47 did significantly
improve CD4+ T cell activation. It is possible that no beneficial
effect with anti-CD172a was seen because not all surface
receptors were sufficiently blocked due to the strong increase
in CD172a expression. Also, the anti-CD172a antibody does
not deplete the Gr1+ cells, so they are still present in the
mixed splenocyte cultures and could circumvent the antibody
blockage through receptor recycling, as well as suppress T cell
functions via other checkpoint inhibitors. The observation that
anti-CD47 treatment only ameliorated CD4+ T cell dysfunction
could similarly be explained by differential receptor recycling
between the CD4+ and CD8+ T cell populations. Another
possibility is that T cell suppression by CD172a involves another
ligand than the classical CD47 after burn injury. For instance,
surfactant protein A and D (SP-A, SP-D) are also ligands for
CD172a and have been attributed immunomodulatory roles,
although they have not been reported to be expressed on
T cells so far (61). Further studies are necessary to identify
the mechanism underlying the restorative effect of anti-CD47
treatment on T cell activation. Given that our data show that
T cells are intrinsically functional after burn injury, enabling
the phagocytosis of dysfunctional T cells through blocking
the “do not eat me” signal upon interaction of CD172a and
CD47 seems unlikely. However, enabling phagocytosis of other
suppressive or dysfunctional cells through blockage of their
respective CD47 molecules may lead to cross-activation of T
cells, thus restoring their function. Increasing T cell priming
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FIGURE 7 | Scald injury leads to an expansion of immature reticulocytes, driving checkpoint-inhibitor expression on Gr1+ cells. CD1 outbred mice were subjected to
scald injury (28% TBSA, full thickness). Controls did not undergo the procedure (ctrl). Spleens were harvested on the indicated days after injury. Numbers of immature
reticulocytes (immRets, CD45−, Ter119+, CD71+) were quantified by flow cytometry. n = 4 (ctrl), n = 6–8 (scald) (A) To assess if these are ingested by myeloid cells,
CD71+ cells were isolated from spleens after scald injury by jet-in-air cell sorting, labeled with CFSE and cultured overnight with unlabeled splenocytes obtained from
control mice. The CFSE signal was quantified by flow cytometry in unquenched samples, as well as after quenching cell-surface signals with trypan blue. n = 4 (B) To
determine if ingestion of immature reticulocytes drives CD172a expression on Gr1+ cells, Ter119+ cells were isolated by magnetic bead separation from spleens after
scald injury and labeled with CFSE. Labeled cells were then incubated overnight with unlabeled splenocytes from control mice. CD172a expression on Gr1+ cells with
and without ingestion of the labeled Ter119+ cells was determined by flow cytometry. n = 4 (C) in vivo numbers of Gr1+ cells with ingested immature reticulocytes
was determined by intracellular Ter119 and CD71 staining and flow cytometry on the indicated days after burn (D) and expression of CD172a compared between
Gr1+ populations with and without ingestion of immature reticulocytes (E) n = 4 (ctrl), n = 6–8 (scald). Graphs depict means ± SEM in addition to each replicate
(A,C–E) or a representative histogram with means ± SEM (B) Outliers were removed when permissible by ROUT method. *p < 0.05 compared to respective control
(A,D), compared to – (C) or compared to control – (E), #p < 0.05 compared to d7 – (E) [one-way ANOVA with Sidak posttest (A,B,D,E) or Student t-test (C)].
is hypothesized to underlie the success of CD47 blockade in
tumor models (62). Additionally, anti-CD47 treatment may have
a T cell-activating effect through CD47 itself: A previous study
in Jurkat cells has shown that anti-CD47 in combination with
anti-CD3 enhanced IL-2 production. This is thought to be due
to anti-CD47 mediated interactions between CD47 and other
plasma membrane molecules, resulting in CD47 providing a T
cell co-stimulatory signal (63).
It is unclear what drives the expansion of CD172a-expressing
Gr1+ cells after burn injury. A study on immunosuppression
by immature reticulocytes in tumor-bearing mice noted an
expansion of CD45+ Ter119+ CD71+ cells (52). Ter119 and
CD71 mark immature reticulocytes, which do not, however,
normally express CD45. Since the study also reported that the
transcriptome of these triple-positive cells strongly resembled
that of MDSCs, we wondered if these cells are, in fact,
Gr1+ cells that have ingested immature reticulocytes. The
phagocytosis of immature reticulocytes could potentially drive
CD172a expression, similar to what has been reported for the
expression of other checkpoint inhibitors after efferocytosis (33–
36). While the presence of immature reticulocytes has previously
been reported in burn patients (64), they have not been studied
in detail yet. It is also unclear if they are present in experimental
burn models. Thus, we first quantified immature reticulocyte
numbers in a time-course after burn. Burn injury did indeed
result in an increase of immature reticulocytes, which became
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significant on PBD7 and continued to rise until PBD11. We
further confirmed that these cells can be ingested by Gr1+ cells
and that CD172a expression is higher on Gr1+ cells that have
ingested immature reticulocytes than those that have not. Our
data thus identify checkpoint inhibitor expression in response to
ingestion of immature reticulocytes as a new pathway mediating
T cell dysfunction after burn injury. Potentially, immature
reticulocytes could also contribute to T cell suppression after
burn themselves, as they have been attributed T cell suppressive
properties in several studies (44, 47, 49).
We did not see a significant increase in immature reticulocytes
acutely after burn injury, however, whereas T cell functionality
was already significantly reduced. This indicates that a separate
mechanism is responsible for the early inhibition of T cell
activation. Our previous work demonstrates that T cells undergo
apoptosis in the acute phase after burn (54), which may play
a role. Further studies are necessary to distinguish between
mediators of acute and persistent T cell dysfunction after
burn injury.
Our data identify MDSCs and immature reticulocytes as new
mediators in T cell suppression and thus as potentially novel
clinical targets. Further studies are needed to determine what
drives the expansion of these two populations. In the future, this
could enable the development of new, urgently needed therapies
to reduce long-term infection susceptibility after burn and lower
infection-related morbidity and mortality in burn victims, which
is unfortunately still the number one cause of postburnmortality.
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